<DOC>
	<DOCNO>NCT01949428</DOCNO>
	<brief_summary>A Field Study Observe Symptom Scores Allergy Medication Usage Subjects History House Dust Mite-Induced Rhinoconjunctivitis</brief_summary>
	<brief_title>House Dust Mite Observational Study</brief_title>
	<detailed_description>House Dust Mites ( HDM ) arachnids infest bedding , carpet , upholstered furniture fabric . Like many allergen , exposure HDMA sensitise patient associate poor lung function , great medication requirement asthma symptom well chronic rhinosinusitis symptom . In contrast allergen , evidence HDMA lead development asthma , addition exacerbate pre-existing asthma HDM-sensitised patient . The propose observational study design gather information subject HDM-related rhinoconjunctivitis .</detailed_description>
	<mesh_term>Conjunctivitis</mesh_term>
	<criteria>Male female , age 1865 year A history moderate severe rhinoconjunctivitis ( sneeze , rhinorrhoea , itchy nose , nasal blockage , and/or itchy/watery/red/sore eye ) consistent allergy HDM least 1 year . Nonasthmatic , asthma control Step 1 2 treatment define GINA least one month . Subjects must 7day reflective TRSS ( i.e. , reflective previous 7 day ) ≥12 must score ≥2 least two individual symptom component . Subjects must Der p Der f specific IgE ≥0.35 kU/L measure ImmunoCAP® . A blood draw HDMspecific IgE must perform Screening period . Subjects must Der p Der f specific IgE ≥0.35 kU/L measure ImmunoCAP® . A blood draw HDMspecific IgE must perform Screening period . Clinically significant confounding symptom allergy relevant local seasonal allergen ( e.g. , ragweed , mugwort , tree , grass , mountain cedar , mould ) complete Screening Observation period outside respective allergy season . Previous immunotherapy treatment HDMA 1 month within 5 year prior screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>HDM Allergy</keyword>
	<keyword>Rhinoconjunctivitis</keyword>
</DOC>